Cancer‐associated fibroblast‐targeted strategy enhances antitumor immune responses in dendritic cell‐based vaccineYasuhiko Ohshio, Kazumasa Ogasawara, Yasushi Itoh et al.|Cancer Science|2014Cited by 88
Predictive biomarkers and effectiveness of MUC1-targeted dendritic-cell-based vaccine in patients with refractory non-small cell lung cancerKoji Teramoto, Keiichi Kontani, Yoshitomo Ozaki et al.|Therapeutic Advances in Medical Oncology|2016Cited by 27